Emerald Advisers’s Gilead Sciences GILD Stock Holding History

Emerald Advisers’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,715	Closed	-$338K	–	248
2016 Q4	$338K	Hold	4,715	–	–	0.01%	224
2016 Q3	$373K	Hold	4,715	–	–	0.02%	291
2016 Q2	$393K	Hold	4,715	–	–	0.02%	291
2016 Q1	$433K	Buy	+4,715	New	+$425K	0.02%	300
2015 Q2	–	Sell	-5,603	Closed	-$581K	–	340
2015 Q1	$581K	Buy	5,603 +1,336	+31%	+$136K	0.03%	273
2014 Q4	$402K	Buy	4,267 +949	+29%	+$98.2K	0.02%	280
2014 Q3	$353K	Sell	3,318 -591	-15%	-$57.9K	0.02%	291
2014 Q2	$324K	Buy	3,909 +1,061	+37%	+$82.6K	0.02%	310
2014 Q1	$202K	Sell	2,848 -592	-17%	-$46.4K	0.01%	347
2013 Q4	$258K	Sell	3,440 -146	-4%	-$10.2K	0.01%	319
2013 Q3	$225K	Sell	3,586 -378	-10%	-$22.6K	0.01%	329
2013 Q2	$203K	Buy	+3,964	New	+$207K	0.01%	329

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Emerald Advisers's GILD Position: Q1 2017 in Review

Emerald Advisers sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 4,715 shares — an estimated $338K sold.

Emerald Advisers first reported a position in GILD in Q2 2013 and held it in 12 quarters. The position peaked at $581K in Q1 2015. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

Emerald Advisers reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
Emerald Advisers sold 4,715 Gilead Sciences shares in Q1 2017, an estimated $338K.
Emerald Advisers first reported a position in Gilead Sciences in Q2 2013 and held it in 12 quarters.
Emerald Advisers's Gilead Sciences position peaked at $581K in Q1 2015.
1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Emerald Advisers's 13F filing for Q1 2017, filed 28 Apr 2017.